These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 18048489)
1. The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis. Xiong Y; Patana AS; Miley MJ; Zielinska AK; Bratton SM; Miller GP; Goldman A; Finel M; Redinbo MR; Radominska-Pandya A Drug Metab Dispos; 2008 Mar; 36(3):517-22. PubMed ID: 18048489 [TBL] [Abstract][Full Text] [Related]
3. Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modeling: confirmation with biochemical evidence. Banerjee R; Pennington MW; Garza A; Owens IS Biochemistry; 2008 Jul; 47(28):7385-92. PubMed ID: 18570380 [TBL] [Abstract][Full Text] [Related]
4. Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid. Battaglia E; Nowell S; Drake RR; Magdalou J; Fournel-Gigleux S; Senay C; Radominska A Drug Metab Dispos; 1997 Apr; 25(4):406-11. PubMed ID: 9107538 [TBL] [Abstract][Full Text] [Related]
5. Interaction of periodate-oxidized UDP-glucuronic acid with recombinant human liver UDP-glucuronosyltransferase 1A6. Battaglia E; Terrier N; Mizeracka M; Senay C; Magdalou J; Fournel-Gigleux S; Radominska-Pandya A Drug Metab Dispos; 1998 Aug; 26(8):812-7. PubMed ID: 9698297 [TBL] [Abstract][Full Text] [Related]
6. The donor substrate specificity of the human beta 1,3-glucuronosyltransferase I toward UDP-glucuronic acid is determined by two crucial histidine and arginine residues. Ouzzine M; Gulberti S; Levoin N; Netter P; Magdalou J; Fournel-Gigleux S J Biol Chem; 2002 Jul; 277(28):25439-45. PubMed ID: 11986319 [TBL] [Abstract][Full Text] [Related]
7. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244 [TBL] [Abstract][Full Text] [Related]
8. Structural and functional studies of UDP-glucuronosyltransferases. Radominska-Pandya A; Czernik PJ; Little JM; Battaglia E; Mackenzie PI Drug Metab Rev; 1999 Nov; 31(4):817-99. PubMed ID: 10575553 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. Miley MJ; Zielinska AK; Keenan JE; Bratton SM; Radominska-Pandya A; Redinbo MR J Mol Biol; 2007 Jun; 369(2):498-511. PubMed ID: 17442341 [TBL] [Abstract][Full Text] [Related]
10. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10? Itäaho K; Laakkonen L; Finel M Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735 [TBL] [Abstract][Full Text] [Related]
11. Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of beta1,3-glucuronosyltransferase I (GlcAT-I). Fondeur-Gelinotte M; Lattard V; Oriol R; Mollicone R; Jacquinet JC; Mulliert G; Gulberti S; Netter P; Magdalou J; Ouzzine M; Fournel-Gigleux S Protein Sci; 2006 Jul; 15(7):1667-78. PubMed ID: 16815917 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of beta 1,3-glucuronyltransferase I in complex with active donor substrate UDP-GlcUA. Pedersen LC; Darden TA; Negishi M J Biol Chem; 2002 Jun; 277(24):21869-73. PubMed ID: 11950836 [TBL] [Abstract][Full Text] [Related]
13. Regiospecificity and stereospecificity of human UDP-glucuronosyltransferases in the glucuronidation of estriol, 16-epiestriol, 17-epiestriol, and 13-epiestradiol. Sneitz N; Vahermo M; Mosorin J; Laakkonen L; Poirier D; Finel M Drug Metab Dispos; 2013 Mar; 41(3):582-91. PubMed ID: 23288867 [TBL] [Abstract][Full Text] [Related]
14. Human UDP-glucuronosyltransferase 2B7. Radominska-Pandya A; Little JM; Czernik PJ Curr Drug Metab; 2001 Sep; 2(3):283-98. PubMed ID: 11513331 [TBL] [Abstract][Full Text] [Related]
15. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform. Kaji H; Kume T Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137 [TBL] [Abstract][Full Text] [Related]
16. Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A. Li D; Fournel-Gigleux S; Barré L; Mulliert G; Netter P; Magdalou J; Ouzzine M J Biol Chem; 2007 Dec; 282(50):36514-24. PubMed ID: 17956868 [TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin. Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114 [TBL] [Abstract][Full Text] [Related]
18. Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10. Starlard-Davenport A; Xiong Y; Bratton S; Gallus-Zawada A; Finel M; Radominska-Pandya A Steroids; 2007 Jan; 72(1):85-94. PubMed ID: 17174996 [TBL] [Abstract][Full Text] [Related]
19. Characterization of UDP-glucuronic acid transport in rat liver microsomal vesicles with photoaffinity analogs. Radominska A; Berg C; Treat S; Little JM; Lester R; Gollan JL; Drake RR Biochim Biophys Acta; 1994 Oct; 1195(1):63-70. PubMed ID: 7918567 [TBL] [Abstract][Full Text] [Related]
20. Human UDP-glucuronosyltransferase isoforms involved in haloperidol glucuronidation and quantitative estimation of their contribution. Kato Y; Nakajima M; Oda S; Fukami T; Yokoi T Drug Metab Dispos; 2012 Feb; 40(2):240-8. PubMed ID: 22028316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]